Taken together, our results demonstrate that the Streptomyces-derived compound NAT-F possesses promising inhibitory effects on proliferation through cell cycle arrest and induces DNA damage in human NSCLC in vitro. This evidence concerns the gene BRD2 and non-small cell lung carcinoma.